Which term describes treatment access under a program for unapproved drugs for AIDS patients?

• A. Orphan Drug Act
• B. Treatment INDs
• C. Expedited Approval
• D. Benoxaprofen

Answer: (B)

Treatment INDs describe giving access to an experimental drug for patients with AIDS who have no good approved options, while the drug is still being studied in a clinical trial. This pathway lets doctors use an investigational therapy for individuals who might benefit but cannot wait for full approval, leveraging an active IND and a reasonable expectation of benefit. It emerged as a crucial way to provide treatment during the AIDS crisis when many patients had limited options.

In this framework, the focus is on access to unapproved drugs under supervision of the trial and regulatory processes. By contrast, the Orphan Drug Act is about incentives to develop drugs for rare diseases, not access mechanisms; expedited approval is about speeding up the process to approve a drug, not about giving unapproved drugs to patients; and benoxaprofen is simply a drug name, not a program for access to unapproved therapies.